Results 71 to 80 of about 377,889 (137)

Vaccine Name Framing, Relationship Status, and Fear: Examining Heterosexual Men's Intention to Vaccinate Against Human Papillomavirus Infection

World Medical &Health Policy, Volume 18, Issue 1, March 2026.
ABSTRACT Against the backdrop of calling for nonfemale‐oriented promotion of vaccination against human papillomavirus (HPV), this study explored three potential names—“HPV Vaccine,” “Cervical Cancer Vaccine,” and “Genital Warts Vaccine”—to promote vaccination against HPV infection among heterosexual men.
Timothy K. F. Fung, Judy Yuen‐man Siu, Ho Man Leung   +2 more
wiley   +1 more source

Drug Delivery Systems for Resiquimod to Control Myeloid‐Derived Suppressor Cells in Cancer Immunotherapy

WIREs Nanomedicine and Nanobiotechnology, Volume 18, Issue 2, March/April 2026.
Myeloid‐derived suppressor cells (MDSCs) are key contributors to cancer immunotherapy failure and major targets in new therapeutic strategies. We highlight therapeutic approaches to counteract their immunosuppressive functions and discuss recent efforts to optimize drug delivery for controlling MDSCs, focusing on resiquimod as a representative drug ...
Yanying He, Yoon Yeo
wiley   +1 more source

Gardasil-9: A global survey of projected efficacy [PDF]

, 2016
© 2016 Elsevier B.V. Human papillomaviruses (HPVs) are the causative agents of human neoplasias such as warts and cancers. There are ∼19 HPV types associated with cancers, which has made it very challenging for first generation HPV vaccines to offer ...
Tumban, Ebenezer, Zhai, Lukai
core   +1 more source

A Phase III, Randomized, Double-Blind, Active-Controlled Non-Inferiority Trial Evaluating the Immunogenicity and Safety of Gardisun, a Quadrivalent Human Papillomavirus Vaccine, Compared with Gardasil^® in Healthy Volunteers Aged 15–35 Years

Vaccines
Background/Objectives: Human papillomavirus (HPV) infection is the leading cause of cervical cancer and is associated with several anogenital and oropharyngeal malignancies.
Erfan Pakatchian, Minoo Mohraz, Mohammad Taghavian, Babak Javadimehr, Hajar Mohammadi Barzelighi, Majid Teymoori-Rad, Mehrdad Ghodsi, Zahra Naderi Saffar   +7 more
doaj   +1 more source

HPV vaccination following cervical intraepithelial neoplasia grade 2 diagnosis and risk of progression

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 2, Page 377-385, February 2026.
HPV vaccination in women undergoing active surveillance for CIN2 does not offer a protective effect against progression to CIN3+. Women should be informed that vaccination is not a substitute for clinical follow‐up and should be encouraged to adhere to recommended surveillance and treatment protocols Abstract Introduction Human papillomavirus (HPV ...
Dina O. Eriksen, Louise Krog, Eva B. Ostenfeld, Pernille T. Jensen, Kathrine D. Lycke, Therese K. Grønborg, Nicolas Wentzensen, Megan A. Clarke, Anne Hammer   +8 more
wiley   +1 more source

Gendering Gardasil: Framing Gender and Sexuality in Media Representations of the HPV Vaccine [PDF]

, 2012
In an age of biomedicine, technologies, drugs, and treatments are expanding in new and diverse ways. Especially relevant to biomedicalization and this research is how such information is conveyed to the public through the media.
Pisciotta, Maura Kathleen
core   +2 more sources

Acceptance of HPV Vaccination: A Systematic Review of Knowledge, Attitudes and Barriers Among Healthcare Practitioners in Low‐ and Middle‐Income Countries

BioMed Research International, Volume 2026, Issue 1, 2026.
Background Cervical cancer is one of the diseases that reflects global inequities. Vaccination against the human papillomavirus (HPV) is one of the main pillars of the World Health Organization (WHO) 2030 cervical cancer 90:70:90 elimination strategy. The role of healthcare practitioners in HPV vaccination acceptance cannot be overemphasized.
Nancy Innocentia Ebu Enyan, Mengying Zhang, Sebastian Ken-Amoah, Michelle King-Okoye, Joyce Agyeiwaa, Richard Sarfo-Walters, Dorothy Addo-Mensah, Patrick Kafui Akakpo, Dorcas Obiri-Yeboah, Lawrence Doi, Cassiano Gonçalves-de-Albuquerque   +10 more
wiley   +1 more source

Political Ideology and HPV Vaccine Awareness: Sex Differences and Nursing Implications Using the Health Information National Trends Survey (HINTS)

Nursing Research and Practice, Volume 2026, Issue 1, 2026.
Background This study aims to investigate the relationship between political ideology and the awareness of human papillomavirus (HPV) and the HPV vaccine and the interaction with sex and race/ethnicity. Methods This cross‐sectional study is a secondary analysis of Health Information National Trends Survey data, based on responses from 3113 American ...
Soojung Jo, Dongjuan Xu, Monica L. Kasting, Nicole Adams, Ateya Megahed Megahed Ibrahim Eleglany   +4 more
wiley   +1 more source

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy

Cost Effectiveness and Resource Allocation, 2017
Background In Italy HPV vaccination with the quadrivalent vaccine (Gardasil®) is offered actively and free of charge to girls aged 12 since 2007. A nine-valent vaccine (Gardasil 9®) received the European market authorization in 2015 to protect, with only
Francesco Saverio Mennini, Paolo Bonanni, Florence Bianic, Chiara de Waure, Gianluca Baio, Giacomo Plazzotta, Mathieu Uhart, Alessandro Rinaldi, Nathalie Largeron   +8 more
doaj   +1 more source

Targeting Vaccine Information Framing to Recipients' Education: A Randomized Trial

Health Economics, Volume 34, Issue 12, Page 2317-2337, December 2025.
ABSTRACT We study the effect of framing informational campaigns scientifically or emotionally on the vaccination uptake of recipients with different educational backgrounds. 7616 Swedish mothers stratified by education received a leaflet on their children's upcoming HPV vaccination opportunity. The leaflet's framing was randomized between emotional and
Alice Dominici, Lisen Arnheim Dahlström
wiley   +1 more source